UK co-ordinating investigator international clinical trial: A Phase 2 Study to Assess the Efficacy and Safety of CAL-101 in Patients with Indolent B-Cell Non-Hodgkin Lymphoma Refractory to Rituximab and Alkylating Agents
- Kim Linton (Other)
Activity: Internal positions, career professional development, other peer review and other › Other › Research